Karen Akinsanya Biography and Net Worth

Insider of Schrödinger

Karen Akinsanya, Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D, joined Schrödinger in 2018. Karen leads our Discovery R&D group with responsibility for preclinical drug discovery and translational research. She has more than 25 years of experience in academia, pharmaceutical R&D, partnerships, and licensing. Karen joined Merck Research Labs in 2005 and held positions of increasing responsibility in clinical pharmacology as a development team leader working on first-in-human studies through late-stage label studies before joining Discovery Preclinical & Early Development as a therapeutic area lead and then a search and evaluation lead in business development. Karen received her Ph.D. from the Royal Postgraduate Medical School at Imperial College in London, in endocrine physiology. After post-doctoral training at Imperial and the Ludwig Institute for Cancer Research (UCL), Karen joined Ferring Pharmaceuticals in R&D working across sites in the UK and US. At Ferring, she led the discovery of a family of dipeptidyl peptidases related to DPPIV and pre-clinical characterization of FDA-approved FIRMAGON® for prostate cancer.

What is Karen Akinsanya's net worth?: The estimated net worth of Karen Akinsanya is at least $25,844.76 as of September 15th, 2021. Dr. Akinsanya owns 1,394 shares of Schrödinger stock worth more than $25,845 as of November 17th. This net worth approximation does not reflect any other investments that Dr. Akinsanya may own. Additionally, Dr. Akinsanya receives an annual salary of $797,740.00 as Insider at Schrödinger. Learn More about Karen Akinsanya's net worth.
How old is Karen Akinsanya?: Dr. Akinsanya is currently 56 years old. There are 6 older executives and no younger executives at Schrödinger. The oldest executive at Schrödinger is Dr. Richard A. Friesner Ph.D., Co-Founder, Scientific Advisory Chairman and Director, who is 71 years old. Learn More on Karen Akinsanya's age.
What is Karen Akinsanya's salary?: As the Insider of Schrödinger, Inc., Dr. Akinsanya earns $797,740.00 per year. The highest earning executive at Schrödinger is Dr. Ramy Farid Ph.D., CEO, President & Director, who commands a salary of $1,060,000.00 per year. Learn More on Karen Akinsanya's salary.
How do I contact Karen Akinsanya?: The corporate mailing address for Dr. Akinsanya and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Karen Akinsanya's contact information.
Has Karen Akinsanya been buying or selling shares of Schrödinger?: Karen Akinsanya has not been actively trading shares of Schrödinger in the last ninety days. Most recently, Karen Akinsanya sold 1,393 shares of the business's stock in a transaction on Friday, October 15th. The shares were sold at an average price of $55.75, for a transaction totalling $77,659.75. Learn More on Karen Akinsanya's trading history.
Who are Schrödinger's active insiders?: Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.
Are insiders buying or selling shares of Schrödinger?: During the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,182 shares worth more than $129,616.27. The most recent insider tranaction occured on October, 15th when insider Margaret Dugan sold 1,531 shares worth more than $27,221.18. Insiders at Schrödinger own 8.6% of the company. Learn More about insider trades at Schrödinger.
Information on this page was last updated on 10/15/2024.

Karen Akinsanya Insider Trading History at Schrödinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/15/2021	Sell	1,393	$55.75	$77,659.75
9/15/2021	Sell	1,394	$61.13	$85,215.22	1,394
6/8/2021	Sell	10,242	$75.54	$773,680.68	6,479
12/18/2020	Sell	13,377	$80.00	$1,070,160.00	13,377
8/17/2020	Sell	3,344	$68.04	$227,525.76	3,344

Karen Akinsanya Buying and Selling Activity at Schrödinger

Schrödinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $18.54

$18.46

$20.46

50 Day Range

MA: $18.72

$16.98

$22.25

2 Week Range

Now: $18.54

$16.67

$38.00

Volume

1,221,118 shs

Average Volume

876,651 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

Karen Akinsanya Biography and Net Worth

What is Karen Akinsanya's net worth?

How old is Karen Akinsanya?

What is Karen Akinsanya's salary?

How do I contact Karen Akinsanya?

Has Karen Akinsanya been buying or selling shares of Schrödinger?

Who are Schrödinger's active insiders?

Are insiders buying or selling shares of Schrödinger?